Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126623651 | 12662365 | 1 | I | 201403 | 20160808 | 20160817 | 20160817 | PER | US-ASTRAZENECA-2016SE85947 | ASTRAZENECA | 681.00 | MON | F | Y | 64.90000 | KG | 20160818 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126623651 | 12662365 | 1 | PS | ANASTRAZOLE | ANASTROZOLE | 1 | Oral | 366 | MG | 20541 | 1 | MG | TABLET | QD | |||||
126623651 | 12662365 | 2 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 0 | 25 | MG | BID | ||||||||
126623651 | 12662365 | 3 | SS | TAMOXIFEN | TAMOXIFEN | 1 | Oral | UNKNOWN | 0 | TABLET | |||||||||
126623651 | 12662365 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126623651 | 12662365 | 1 | Breast cancer |
126623651 | 12662365 | 2 | Hypertension |
126623651 | 12662365 | 4 | Hypertension |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126623651 | 12662365 | Electrocardiogram T wave inversion | |
126623651 | 12662365 | Hypertension | |
126623651 | 12662365 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126623651 | 12662365 | 1 | 2013 | 0 |